Abstract
Varicella, which is caused by the varicella zoster virus (VZV), is a common infectious disease affecting children. Varicella vaccines have been used for decades; however, vaccination policies vary across countries because of differences in VZV epidemiology. The basic reproductive number (Formula presented.) a transmissibility measure parameter, also differs from country to country. In this study (Formula presented.) for varicella was estimated in South Korea using the contact rate matrix derived from averaged POLYMOD contact data, the Korean population, and proportionality factor fitted to the Korean VZV seroprevalence (Formula presented.) for varicella in South Korea was estimated to be 5.67 (95% CI: 5.33, 6.33). Therefore, to reach the herd immunity threshold, the critical vaccine coverage should be greater than 82.4% with a perfect vaccine, or the primary vaccine failure proportion should be less than 17.6% with 100% coverage. Because of the relatively low seroconversion rate and rapidly waning immunity after one-dose vaccination in South Korea, the herd immunity threshold is difficult to attain with only a one-dose vaccine. Two doses of vaccination may be necessary to effectively interrupt varicella transmission and maintain herd immunity in South Korea. The study results can help guide the decision-making on an effective varicella vaccination policy in South Korea.
Original language | English |
---|---|
Pages (from-to) | 2488-2493 |
Number of pages | 6 |
Journal | Human Vaccines and Immunotherapeutics |
Volume | 17 |
Issue number | 8 |
DOIs | |
Publication status | Published - 2021 |
Bibliographical note
Funding Information:This work was supported by a National Research Foundation of Korea (NRF) grant funded by the Korea Government (Ministry of Science and ICT) (No. 2018R1A2B6006178) and by NRF-2015R1A5A1009350 We would like to thank Won Suk Choi for providing the seroprevalence data.
Publisher Copyright:
© 2021 Taylor & Francis Group, LLC.
All Science Journal Classification (ASJC) codes
- Immunology and Allergy
- Immunology
- Pharmacology